CB1 antagonist 2

CAS No. 614726-85-1

CB1 antagonist 2( AM4113 )

Catalog No. M24614 CAS No. 614726-85-1

CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 33 In Stock
5MG 53 In Stock
10MG 87 In Stock
25MG 174 In Stock
50MG 335 In Stock
100MG 500 In Stock
500MG 1098 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CB1 antagonist 2
  • Note
    Research use only, not for human use.
  • Brief Description
    CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.
  • Description
    CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AM4113
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    CB1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    614726-85-1
  • Formula Weight
    380.66
  • Molecular Formula
    C17H12Cl3N3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 60 mg/mL (157.62 mM; Need ultrasonic); H2O: < 0.1 mg/mL (insoluble)
  • SMILES
    Cc1c(-c(cc2)ccc2Cl)n(-c(ccc(Cl)c2)c2Cl)nc1C(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Li, S. , et al. "4-methyl-1h-diaryl pyrazole derivatives and their uses as medicament." WO, WO2007121687 A1.
molnova catalog
related products
  • GAT-211

    GAT-211 (GAT211) is a selective cannabinoid 1 receptor (CB1R) positive allosteric modulator with pKb of 7.26, Arrestin2 EC50 of 775 nM.

  • CB2 modulator 1

    CB2 modulator 1 is a potent CB2 modulator. It can be used for the research for immune disorders, osteoporosis, inflammation, renal ischemia.

  • Bay 59-3074

    A potent, selective cannabinoid CB1/CB2 receptor partial agonist with Ki of 48.3, and 45.5 nM for human CB1 and human CB2 receptors, respectively.